Researchers at the University of North Carolina at Chapel Hill recently received a $3.5 million NIH award for their study “Gene Expression Patterns in Human Tumors Identified Using Transcript Sequencing.” The study is being led by Charles Perou, PhD. According to the University of North Carolina at Chapel Hill website, Dr. Perou is a distinguished professor of genomics at the university whose research interests include characterizing the biological diversity of human tumors using genomics, molecular genetics and cell biology.
Lab suppliers working to sell lab products and life science products may be interested in the latest funding news at Emory University. Recently this year, Emory University researchers led by Dr. Bali Pulendran received a $2.9 million NIH award to study systems biological analysis of innate and adaptive responses to vaccination. According to the Emory University website, Dr. Pulendran is a Professor in the Department of Pathology and Laboratory Medicine at the Emory University School of Medicine. The NIH RePORTER includes an abstract with a description of the project receiving funding, which says:
Researchers at the University of Arizona, Tucson recently received a $1.2 million award from the NIH for the Chemoprevention of Skin Cancer Program Project, led by David Alberts, MD. The University of Arizona website says that Alberts has spent his career focusing on translational cancer prevention and treatment research. His main area of expertise is laboratory-based and clinical research investigating the chemoprevention and treatment as such devastating cancers as breast cancer, colon cancer, ovary cancer and skin cancer. He served as the University of Arizona Cancer Center’s director from 2005 to June 2013. The abstract for the project receiving new NIH funding on NIH RePORTER states:
The Institute for Clinical and Translational Science at the University of California, Irvine recently received a $3.1 million award from the NIH. According to the University of California, Irvine’s website, the institute’s goal is to increase the number of discoveries of treatments for all human diseases and injuries. The Institute for Clinical and Translational Science provides services in the following nine areas: